Clinical Profile, Follow-up, and Role of Neuroimaging in Pediatric Guillain-Barré Syndrome in the COVID Era: An Ambispective Study
Journal of Child Neurology · 2023
DOI: 10.1177/08830738231184089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child Neurology, 2023. Verfasst von Lokesh Saini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background
To define the varied presentations of Guillain-Barré syndrome in children in the COVID era and 6 months’ follow-up outcome.
Methods
Ambispective study of 15 months’ duration involving children with Guillain-Barré syndrome aged 1 month to 18 years at a tertiary care pediatric hospital. They were categorized into groups A and B based on COVID-19 serology testing. Hughes Disability Scale was used for disability assessment. Modified Rankin scale was used for improvement assessment in follow-up.
Results
Of 19 children with Guillain-Barré syndrome, 9 (47%) were females and 10 (53%) were males. Groups A and B had children with negative (8) and positive serology (11), respectively. The most common presentation in both groups was motor weakness. Post-COVID pediatric Guillain-Barré syndrome presented with variants of Guillain-Barré syndrome rather than the classical form ( P = .03). In group B, patients with elevated inflammatory markers had poor response to intravenous immunoglobulin, and 5 of 11 patients had good response to pulse steroids, probably depicting an inflammation-predominant pathology.
Conclusion
Post-COVID Guillain-Barré syndrome in children presented with Guillain-Barré syndrome variants rather than the classic form. Neuroimaging is of great value in both confirming Guillain-Barré syndrome diagnosis and excluding differentials. Patients with elevated inflammatory markers and residual weakness may be given a pulse steroid trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
- Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
- Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
- Department of Neurology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
ORCID-Profile: Lokesh Saini, Pradeep Kumar Gunasekaran
Zitieren
APA
Saini, L., Krishna, D., Gunasekaran, P. K., Tiwari, S., Kumar, P., Goyal, J. P., Khera, D., Choudhary, B., Didel, S., Gaur, R., Laxmi, V., Panda, S., & Singh, K. (2023). Clinical Profile, Follow-up, and Role of Neuroimaging in Pediatric Guillain-Barré Syndrome in the COVID Era: An Ambispective Study. Journal of Child Neurology. https://doi.org/10.1177/08830738231184089
Vancouver
Saini L, Krishna D, Gunasekaran PK, Tiwari S, Kumar P, Goyal JP, et al. Clinical Profile, Follow-up, and Role of Neuroimaging in Pediatric Guillain-Barré Syndrome in the COVID Era: An Ambispective Study. Journal of Child Neurology. 2023. doi:10.1177/08830738231184089
BibTeX
@article{Saini2023,
author = {Saini, Lokesh and Krishna, Deepthi and Gunasekaran, Pradeep Kumar and Tiwari, Sarbesh and Kumar, Prawin and Goyal, Jagdish Prasad and Khera, Daisy and Choudhary, Bharat and Didel, Siyaram and Gaur, Ravi and Laxmi, Veena and Panda, Samhita and Singh, Kuldeep},
title = {Clinical Profile, Follow-up, and Role of Neuroimaging in Pediatric Guillain-Barré Syndrome in the COVID Era: An Ambispective Study},
journal = {Journal of Child Neurology},
year = {2023},
doi = {10.1177/08830738231184089}
}
EUVIMED